Jacob Green, M.D.
Specialties:
Cardiology, Cardiovascular Disease, Interventional Cardiology, Peripheral Vascular
Dr. Jacob Green is Board Certified in Cardiovascular Disease, having received his training at Emory University in Atlanta, Georgia; where he completed an additional fellowship in Interventional Cardiology. Dr. Green received his Doctor of Medicine degree from The University of Arizona.
Dr. Green specializes in coronary and peripheral arterial disease diagnosis and treatment including minimally invasive techniques such as angioplasty and stenting. He has particular interest and specialized training in catheter-based treatment of valvular and structural heart disease including aortic stenosis (AS), patent foramen ovale (PFO) and atrial septal defects (ASD).
Locations
Tri-City Cardiology – San Tan Valley
36543 N. Gantzel Rd., Building 15, Suite 101, San Tan Valley AZ 85140
Education/Training
Medical School - University of Arizona College of Medicine, Tucson, AZ
Residency - Emory University Affiliated Hospitals
Fellowship - Emory University Affiliated Hospitals
Recognition/Research/Publications
Research:
- 2007 – 2008: Cardiovascular clinical research fellow, Division of Valvular Interventional and Structural Heart Disease, Andreas Gruentzig Cardiovascular Center, Emory University.
Ongoing research projects:
- Co-Investigator: PARTNER (Placement of AoRTic TraNscathetER Valves) Trial- prospective, randomized-controlled, multi-center pivotal trial evaluating the safety and effectiveness of the Edwards SAPIEN™ Transcatheter Heart Valve in a stratified population of high risk patients (two patient populations versus section controls). Institutional PI: Peter Block, MD.
- Co-Investigator: VIVID Feasibility Study (Valvular and Ventricular Improvement via iCoapsys Delivery Feasibility Study)- prospective, non-randomized, single-arm feasibility evaluation of the iCoapsys System in patients with functional mitral valve insufficiency caused by annular dilation and/or papillary muscle displacement. Institutional PI: Peter Block, MD
- Co-Investigator: EVEREST II- A Pivotal Study of the Evalve® Cardiovascular Valve Repair System: The Endovascular Valve Edge-to-Edge REpair STudy.
- Temporary percutaneous left ventricular assist support to palliate end-stage cardiomyopathy- pending IRB approval. PI: Vasilis Babaliaros, MD.
- 8/03-8/04: Retrospective analysis from the Congestive Heart Failure Database at Emory University: The predictive value of the electrocardiogram in non-ischemic dilated cardiomyopathy. Preceptor- Andrew L. Smith, M.D.
- 9/95-7/97: Ongoing Evolutionary Genetics study: The genetics of postponed senescence in Drosophila- Evolutionary biology/genetics laboratory, Arizona State University,West. Preceptor- Joseph L. Graves, Jr., PhD.
Publications:
- 2008: Babaliaros, VC, Liff D, Chen EP, Rogers JH, Brown RA, Thourani VH, Guyton RA, Lerakis S, Stillman AE, Raggi P, Cheesborough JE, Veladar E, Green JT, Block PC. Can balloon aortic valvuloplasty help determine the appropriate Sizing for transcatheter aortic valve replacement? J Am Coll Cardiol Intv 2008; 1:580-6.
- 2008: Babaliaros V, Green J, Lerakis S, Lloyd M, Block P. Emerging applications for transseptal left heart catheterization: old techniques for new procedures. J Am Coll Cardiol 2008;51(22):2116-22.
- 2008: Mavromatis K, Aznaouridis K, Ghasemzadeh N, Forghani Z, Veledar E, Sutcliffe D, Mihretu T, Kamineni T, Ishaque M, Reddy PK, Green J, Taylor WR, Quyyumi AA. Circulating endothelial progenitor cell Activity as a predictor of cardiovascular outcomes. J Am Coll Cardiol 2008;51(10): A-305.
- 2008: Babaliaros V, Green J, Block P. Percutaneous mitral valve repair: future therapies for the treatment of mitral regurgitation. Cardiac Surgery Today 2008; 4(1)18-22. (Publisher: Remedica Medical Education and Publishing).
- 2007: Green, JT, Babaliaros, V, Block, P. Aortic valve replacement: an overview of percutaneous applications. Cardiac Interventions Today, June 2007.
- 2007: Green J, Babaliaros V, Block P. Current transcatheter repair strategies for mitral regurgitation. US Cardiovascular Disease 2007; Issue 2:57-59. (Publisher: Touch Briefings).
- 2007: Green J, Block P. XX and risky business. (Commentary) Journal of Invasive Cardiology 2007;19(9):375-376.
- 2007: Green J, Babaliaros V, Liff D, Chen E, Guyton R, Thourani V, Raggi P, Stillman A, Lerakis S, Rogers J, Brown R, Block P. Understanding the role of aortic valve calcium and annulus measurements in the appropriate sizing of transcatheter heart valves. Georgia ACC annual meeting 2007 (Poster).
- 2007: Kalogeropoulos A, Green J, Babaliaros V, Lerakis S, Block P, Martin RP. Short-axis left ventricular function is impaired in asymptomatic patients with mitral regurgitation and preserved LV dimensions: insights from two-dimensional strain imaging. ESC Congress 2007 (Abstract).
- Green JT. Cath of the Month: 19-Year-old man with a known cardiac history presented with intermittent exertional chest discomfort and dyspnea on exertion [transcript]. Cardiosource Web Site, American College of Cardiology Foundation. Available at https://www.cardiosource.com/casestudies/casestudy.asp?studyid=1057. Accessed August 15, 2007.
- Green JT, Gore TB. Cath of the Month: An 84-Year-Old Woman Presents in Cardiogenic Shock [transcript]. Cardiosource Web Site, American College of Cardiology Foundation. Available at https://www.cardiosource.com/casestudies/casestudy.asp?studyid=1201. Accessed May 22, 2008.
- Green J, Lutz J, Block P. Long-term follow-up on transcatheter closure of post-infarction ventricular septal defect: a case report and review. Manuscript submitted.